ECM
RXDX

ExodusPoint Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

ExodusPoint Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-58,070
Closed -$6.39M – 2128
2022
Q4 		$6.39M Buy
+58,070
New +$6.39M 0.09% 272